GLG News by Physicians who Implant Silicone Breast Implants
Request a free trial
August 7, 2008
I totally agree with the fact that currently the dermataologists are avoiding the skin cancer patients in favor of the filler and Botox cleients. If howver the third party insurers would compensate the physicians for their skin lesion removals properly this might not be occuring a sit is.
Analysis of: As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com
Author: GLG Expert Contributor
Analysis of: As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com
Author: GLG Expert Contributor
There is more to esthetics than just the use of lasers and fillers...and a well trained plastic surgeon can give a far broader number of options to the patient than a family physician or gynecologist If the derms want to do this skin rejuvenation....who is to treat rosacea,acne skin...
July 31, 2008Dermatologists? I worry more about the Family practitioners, Ob-Gyns, and Internists...
Analysis of: As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com
Author: Robert Frank, Owner, Aria Cosmetic and Reconstructive Surgery
As insurance reimbursements decline, everyone suddenly thinks they're a cosmetic surgeon.
July 8, 2008And yet, another filler? Is this the Holy Grail?
Analysis of: FDA Approves EVOLENCE®, a New Generation Collagen-Based Facial Filler | www.investor.jnj.com
Author: Alan Zaccaria, Plastic Surgeon, Alan Zaccaria, MD, FACS
Over the past few years, noninvasive cosmetic procedures have skyrocketed. Soft tissue injectable fillers are among those procedures that are rapidly growing. Up until now, hyaluronic acid (HA) fillers have been the mainstay. With the emergence of Envolence, we have a new twist on...
July 3, 2008
why are we going backwards
Analysis of: FDA Approves EVOLENCE®, a New Generation Collagen-Based Facial Filler | www.investor.jnj.com
Author: GLG Expert Contributor
Analysis of: FDA Approves EVOLENCE®, a New Generation Collagen-Based Facial Filler | www.investor.jnj.com
Author: GLG Expert Contributor
makes no sense to introduce a product that does not last as long as others on the market unless you are going t sell it to the patient at a substantial prce savings. Even in that scenario, needle fatigue wil eventually make the patient seek a different filler.
May 27, 2008Stay Away From Liquid Silicone Injections.
Analysis of: Renal Failure Linked to Cosmetic Soft-Tissue Filler Injections | www.medscape.com
Author: Alan Zaccaria, Plastic Surgeon, Alan Zaccaria, MD, FACS
Only FDA approved fillers administered by experienced, licensed physicians should be injected into patients. Also, the small volumes that are used today should not pose systemic problems that were seen in this article.
March 14, 2008Phase 2 trials show significantly improved scars
Analysis of: Juvista Phase II Trial Results in Scar Revision and Breast Augmentation Surgery | www.renovo.com
Author: Robert Frank, Owner, Aria Cosmetic and Reconstructive Surgery
Juvista appears to be effective in improving scar quality according to recently released Phase II results. Renovo reported no clinical improvement in breast augmentation scars treated with a single injection of the drug.
February 7, 2008Botox competitors can't come soon enough
Analysis of: Efficacy of Botulinum Toxin Does Not Sag Over Time | www.medscape.com
Author: Robert Frank, Owner, Aria Cosmetic and Reconstructive Surgery
Botox from Allergan has enjoyed an exclusive monopoly for the past nine years. Alternative drugs do not appear to be available as soon as was hoped.
December 14, 2007Topical "Botox"--Sounds Like a Winner
Analysis of: Medicis and Revance Announce Strategic Collaboration | www.pipelinereview.com
Author: Alan Zaccaria, Plastic Surgeon, Alan Zaccaria, MD, FACS
It is not unexpected that Medicis is expanding into the "Botox" business since its rival company, Allergan, has a monopoly on the market. Allergan also has Juviderm, which competes directly with Restylane, the hit product by Medicis. This will place Medicis back into the competitive market...
November 20, 2007
Is TB-403 usefull in the Treatment of Hemangiomas?
Analysis of: ThromboGenics and BioInvent Announce Publication of Exciting Data on a Novel Class of Angiogenesis Inhibitors in Cell | www.pipelinereview.com
Author: GLG Expert Contributor
Analysis of: ThromboGenics and BioInvent Announce Publication of Exciting Data on a Novel Class of Angiogenesis Inhibitors in Cell | www.pipelinereview.com
Author: GLG Expert Contributor
This type of treatment based on anti-PGIF antibodies may be a way to treat complex Hemangiomas. The success of Interferon alpha-2 showed the importance of searching angiogenic inhibitors. As TB-403 doesn't damage normal vessels it may be used in small children.
September 25, 2007
Physician House Calls- A potential major trend in the health care industry
Analysis of: The New York Times | www.nytimes.com
Author: GLG Expert Contributor
Analysis of: The New York Times | www.nytimes.com
Author: GLG Expert Contributor
Physician house calls may represent an emerging major trend in fee-for-service health care delivery. The urgent care center emerged in the 80's and 90's as a novel way for patients to avoid emergency rooms. Of course, this is based on the patient's willingness to pay a fee that is not covered by insurance....
Page : 1 2 3 4 5 Next1 to 10 of 45
More GLG News in
Healthcare
Most Popular:
Source Article | Expert Analyses
Use of Antipsychotics in Children Is Criticized
www.nytimes.com
Scientists recommend 'black box' for Avastin
www.fiercepharma.com
Are Costly Diabetes Pills Doing Any Good?
www.pharmalot.com
How a Drug Maker Tries to Outwit Generics
online.wsj.com
Use of Antipsychotics in Children Poses Risks of Adverse Effects
November 26, 2008
Avastin and clots? News to me. Black box warning? Why?
November 24, 2008
Off Label Use Can Be Prevented
November 24, 2008
Gardasil will most certainly be approved for boys
November 24, 2008
Medivations's (MDVN) Dimebon - We've Seen This Movie Before
November 24, 2008

